US Patent Issued to NIPPON ZENYAKU KOGYO on Jan. 27 for "Monoclonal antibody or antibody fragment against canine CD20" (Japanese Inventor)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,535, issued on Jan. 27, was assigned to NIPPON ZENYAKU KOGYO Co. LTD. (Koryama, Japan).

"Monoclonal antibody or antibody fragment against canine CD20" was invented by Takuya Mizuno (Yamaguchi, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A monoclonal antibody against canine CD20 having a more excellent effect than existing antibodies having a heavy chain variable region consisting of an amino acid sequence of SEQ ID NO: 1 or an amino acid sequence in which one or several amino acids are deleted, substituted, or added in the amino acid sequence of SEQ ID NO: 1, and a light chain variable region consisting of an amino acid sequence of SEQ ID N...